Related Experiment Video
Updated: Aug 2, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Assessing the impact of HIV disease
1Department of Occupational Therapy, University of Puget Sound, Tacoma, Washington 98416.
Summary
HIV disease significantly impacts daily life, affecting work, leisure, and emotional behaviors in symptomatic stages. Prolonged functional deficits worsen these behavioral impacts.
Area of Science:
- Medical Sociology
- Behavioral Medicine
- Public Health
Background:
- HIV disease is a progressive condition impacting individuals physically and behaviorally.
- Understanding the behavioral impact is crucial for comprehensive patient care and support.
- Previous research has explored various aspects of HIV/AIDS, but a detailed analysis of behavioral dysfunction across disease stages is needed.
Purpose of the Study:
- To define HIV disease as a four-stage process.
- To measure behavioral dysfunction in symptomatic HIV disease using the Sickness Impact Profile (SIP).
- To identify specific behavioral domains most affected by HIV disease.
Main Methods:
- Utilized the Sickness Impact Profile (SIP) for assessment.
- Sample comprised 15 individuals with Stage 3 or Stage 4 (symptomatic) HIV disease.
- Analyzed impact on work, leisure, cognitive, and emotional behaviors.
Main Results:
- Symptomatic HIV disease (Stage 3/4) significantly affects work, leisure, cognitive, and emotional behaviors.
- A diagnosis of Acquired Immunodeficiency Syndrome (AIDS) did not correlate with increased dysfunction severity.
- Longer duration of functional deficits led to broader impacts across SIP categories and overall scores.
Conclusions:
- HIV disease presents a progressive, multi-stage process with significant behavioral consequences.
- Behavioral dysfunction, particularly in work and emotional domains, is a key feature of symptomatic HIV.
- The duration of illness, rather than a specific diagnosis like AIDS, is a critical factor in the extent of behavioral impairment.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.